A slim majority of FDA advisory panelists rejected that the benefits of a radiofrequency renal denervation system outweigh the risks for use in adults with uncontrolled hypertension despite use of antihypertensive medications.\n\n https://yamcode.com/hilary-says-wants-update-2245-09192023-163712 https://yamcode.com/raw/hilary-says-wants-update-2245-09192023-163712 https://yamcode.com/obama-says-wants-update-2453-2 https://yamcode.com/raw/obama-says-wants-update-2453-2 https://yamcode.com/china-president-says-wants-update-1408 https://yamcode.com/raw/china-president-says-wants-update-1408